Back to Search
Start Over
N-cadherin regulates mammary tumor cell migration through Akt3 suppression.
- Source :
-
Oncogene [Oncogene] 2013 Jan 24; Vol. 32 (4), pp. 422-30. Date of Electronic Publication: 2012 Mar 12. - Publication Year :
- 2013
-
Abstract
- N-cadherin is a cell-cell adhesion molecule that plays a role in breast cancer metastasis. Here, we show that in vivo expression of N-cadherin in the PyMT mouse model, which enhances mammary tumor metastasis, results in selective inhibition of Akt3 expression and phosphorylation. Similarly, exogenous expression of N-cadherin in PyMT or MCF-7 mammary tumor cells enhanced cell motility and caused a dramatic reduction in Akt3 expression and phosphorylation. Moreover, knockdown of Akt3 in PyMT tumor cells increased cell motility and disrupted mammary morphogenesis, but had no effect on cell proliferation. Conversely, overexpression of wild-type Akt3 in PyMT-N-cadherin cells inhibited cell motility promoted by N-cadherin. Taken altogether, these findings demonstrate that N-cadherin suppresses Akt3 to promote cell motility and highlight the intricate regulation of Akt isoforms by N-cadherin during metastasis.
- Subjects :
- Animals
Cadherins genetics
Cell Growth Processes physiology
Cell Line
Cell Line, Tumor
Cell Movement genetics
Female
HEK293 Cells
Humans
MCF-7 Cells
Mammary Neoplasms, Experimental enzymology
Mammary Neoplasms, Experimental genetics
Mice
Neoplasm Metastasis
Phosphorylation
Proto-Oncogene Proteins c-akt genetics
Receptors, Fibroblast Growth Factor genetics
Receptors, Fibroblast Growth Factor metabolism
Cadherins metabolism
Cell Movement physiology
Mammary Neoplasms, Experimental metabolism
Mammary Neoplasms, Experimental pathology
Proto-Oncogene Proteins c-akt antagonists & inhibitors
Proto-Oncogene Proteins c-akt metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5594
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Oncogene
- Publication Type :
- Academic Journal
- Accession number :
- 22410780
- Full Text :
- https://doi.org/10.1038/onc.2012.65